These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32498921)

  • 21. Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
    Wollenweber T; Kretschmer-Chott E; Wurm R; Rasul S; Kulterer O; Rettl R; Duca F; Bonderman D; Sühs KW; Hacker M; Traub-Weidinger T
    J Nucl Cardiol; 2023 Feb; 30(1):357-367. PubMed ID: 35817943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep Learning-Enabled Quantification of
    Miller RJH; Shanbhag A; Michalowska AM; Kavanagh P; Liang JX; Builoff V; Fine NM; Dey D; Berman DS; Slomka PJ
    J Nucl Med; 2024 Jul; 65(7):1144-1150. PubMed ID: 38724278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of
    Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
    Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of serial
    Ross JC; Hutt DF; Burniston M; Grigore SF; Fontana M; Page J; Hawkins PN; Gilbertson JA; Rowczenio D; Gillmore JD
    Amyloid; 2022 Mar; 29(1):38-49. PubMed ID: 34704883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial scanning with
    Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S
    J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in
    Rettl R; Calabretta R; Duca F; Binder C; Kronberger C; Willixhofer R; Poledniczek M; Donà C; Nitsche C; Beitzke D; Loewe C; Auer-Grumbach M; Bonderman D; Kastl S; Hengstenberg C; Badr Eslam R; Kastner J; Bergler-Klein J; Hacker M; Kammerlander A
    Amyloid; 2024 Mar; 31(1):42-51. PubMed ID: 37599395
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis.
    Sperry BW; Gonzalez MH; Brunken R; Cerqueira MD; Hanna M; Jaber WA
    J Nucl Cardiol; 2019 Oct; 26(5):1630-1637. PubMed ID: 29344917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
    Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
    Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of Myocardial
    Papathanasiou M; Kessler L; Bengel FM; Jakstaite AM; Kersting D; Varasteh Z; Luedike P; Carpinteiro A; Herrmann K; Rassaf T; Rischpler C
    J Nucl Med; 2023 Jul; 64(7):1083-1086. PubMed ID: 37290801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
    Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
    J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac scintigraphy with
    de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
    Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.
    Treibel TA; Bandula S; Fontana M; White SK; Gilbertson JA; Herrey AS; Gillmore JD; Punwani S; Hawkins PN; Taylor SA; Moon JC
    J Cardiovasc Comput Tomogr; 2015; 9(6):585-92. PubMed ID: 26209459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S
    J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS; Park DY; Min BH; Lee SJ; Yoon JK
    BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
    Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.
    Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M
    J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.